Real-World Study of the Treatment Patterns of Patients Diagnosed with Therapy-Related AML or AML-MRC in England between 2013 and 2020 Using the Cancer Analysis System Database

被引：0
|
作者：
Legg, Alex [1 ]
Muzwidzwa, Ruvimbo [2 ]
Adamson, Elizabeth [2 ]
Wilkes, Emily [2 ]
Medalla, Greg [1 ]
机构：
[1] Jazz Pharmaceut, Oxford, England
[2] IQVIA Inc, London, England
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1248
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
    Jacoby, Meagan A.
    Finn, Laura
    Emadi, Ashkan
    Saba, Nakhle S.
    Powell, Bayard L.
    Seiter, Karen
    Garcia, Rosella
    Faderl, Stefan
    Male, Heather J.
    LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2539 - 2542
  • [2] CPX-351 FOR THE TREATMENT OF NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA (TAML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC): AN ANALYSIS OF CLINICAL BENEFIT
    Chung, K. C.
    Ryan, R. J.
    Louie, A. C.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [3] Outcome of Patients with Newly-Diagnosed Therapy-Related AML (t-AML) and AML with Myelodysplasia-Related Changes (AML-MRC) Treated with Liposomal Daunorubicin and Cytarabine (CPX-351) at an Academic Community-Based Health System
    Khoury, John
    Anusim, Nwabundo
    Macari, David
    Duenn, Angela
    Jaiyesimi, Ishmael
    BLOOD, 2019, 134
  • [4] CREST-UK: CPX-351 Real-World Effectiveness and Safety Study for the Treatment of Newly Diagnosed Therapy-Related AML and AML with Myelodysplasia-Related Changes in the UK
    Mehta, Priyanka
    Khan, Anjum
    Maddox, Jamie
    Floisand, Yngvar
    Whitmill, Richard
    Cuadras, Daniel
    Pedros, Montse
    Park, Saemi
    Medalla, Greg
    Legg, Alex
    Campbell, Victoria Louise
    BLOOD, 2022, 140 : 6152 - 6154
  • [5] USING A BUDGET IMPACT MODEL (BIM) AS A DECISION-MAKING TOOL AT THE HOSPITAL LEVEL IN FRANCE: AN EXAMPLE OF CPX-351 IN PATIENTS WITH NEWLY DIAGNOSED THERAPY-RELATED AML (T-AML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC)
    Monnier, R.
    Bourguignon, S.
    Guindeuil, G.
    Pawlak, M.
    VALUE IN HEALTH, 2020, 23 : S450 - S450
  • [6] Trends on treatment patterns in patients with newly diagnosed AML: Preliminary findings from a real-world analysis
    Alessandrini, Ester Rita
    Moreira, Jeverson
    Simon, Virginie
    Mallet, Oscar
    Gamaoun, Rihab
    Pean, Romane
    Hamkoung, Gauvain
    Zuo, Yue
    Reppelin, Theophile
    Kertous, Mehdi
    Templier, Alexandre
    Mounedji, Nadjat
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] TREATMENT PRACTICE PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HRU), AND COSTS IN NEWLY DIAGNOSED PATIENTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA (TAML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC) IN A UNITED STATES (US) COMMERCIALLY INSURED POPULATION
    Hagiwara, M.
    Sharma, A.
    Chung, K. C.
    Delea, T. E.
    VALUE IN HEALTH, 2018, 21 : S27 - S27
  • [8] Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia Related Changes
    Jensen, Ivar S.
    Wu, Elizabeth
    Sacks, Naomi C.
    Cyr, Philip L.
    Chung, Karen C.
    AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (07): : 380 - 386
  • [9] CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK
    Mehta, Priyanka
    Campbell, Victoria
    Maddox, Jamie
    Floisand, Yngvar
    Kalakonda, Anita J. M.
    O'Nions, Jenny
    Coats, Thomas
    Nagumantry, Sateesh
    Hodgson, Katherine
    Whitmill, Richard
    Amott, Ian
    Flynn, Gillian
    Taussig, David
    Zhao, Rui
    Cunningham, Nicholas
    Roset, Montse
    Cuadras, Daniel
    Medalla, Greg
    Kuter, Hayley
    Park, Saemi
    Legg, Alex
    Khan, Anjum B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1326 - 1336
  • [10] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    BLOOD, 2016, 128 (22)
12345